Your enquiry has been submitted
Bile Esculin Azide Agar, Granulated
Plate Count#CC293D
Intended Use
Recommended for isolation and presumptive identification of faecal Streptococci. The composition and performance criteria of this medium are as per the specifications laid down in ISO 7899-2:2000 and ISO 11333:2014, Amd.2: 2020.
Composition
ISO 7899-2:2000 Specification - Bile Esculin Azide Agar
| Ingredients | g/L |
|---|---|
| Tryptone | 17,0 g |
| Peptone | 3,0 g |
| Yeast extract | 5,0 g |
| Ox-bile, dehydrated | 10,0 g |
| Sodium chloride (NaCl) | 5,0 g |
| Aesculin | 1,0 g |
| Ammonium iron(III) citrate | 0,5 g |
| Sodium azide (NaN3) | 0,15 g |
| Agar | 8-18.000 |
| Final pH (at 25°C) | 7.1±0.1 |
Bile Esculin Azide Agar, Granulated® GM493I
| Ingredients | g/L |
|---|---|
| Tryptone | 17.000 |
| Peptone | 3.000 |
| Yeast extract | 5.000 |
| Bile # | 10.000 |
| Sodium chloride | 5.000 |
| Esculin | 1.000 |
| Ferric ammonium citrate | 0.500 |
| Sodium azide | 0.150 |
| Agar | 15.000 |
| Final pH (at 25°C) | 7.2±0.2 |
**Formula adjusted, standardized to suit performance parameters
# Equivqlent to Oxgall
Directions
Suspend 56.65 grams in 1000 ml purified / distilled water. Heat to boiling to dissolve the medium completely. Sterilize by autoclaving at 15 lbs pressure (121°C) for 15 minutes. Cool to 45-50°C. Mix well and pour into sterile Petri plates.
Principle And Interpretation
Group D Streptococci possess the group D lipoteichoic acid antigen in their cell walls. Former Group D species, which are predominant normal inhabitants of the human gastrointestinal tract, are termed as faecal Streptococci or Enterococci (1). The unique ability of Enterococci to split esculin was reported by Meyer and Schonfeld (2). Enterococci and Group D Streptococci hydrolyse esculin to esculetin and dextrose, which reacts with ferric citrate producing brownish black precipitate (3). The use of esculin hydrolysis in identification of Enterococci was first cited by Rochaix (4). Bile Esculin Agar was originally formulated by Swan (5) for the isolation and identification of Group D Streptococci from food. Facklam and Moody (6,7) further reported that using Bile Esculin Agar, Group D Streptococci could be differentiated from non Group D Streptococci. Bile Esculin Agar was also shown to aid differentiation of Enterobacteriaceae, Klebsiella, Enterobacter, Serratia from other Enterobacteriaceae genera (8) on the basis of esculin hydrolysis. However, other tests such as salt tolerance should be performed for identifying Enterococci (9).
Bile Esculin Azide Agar is a modification of Bile Esculin Agar (5,6) as per Isenberg (10). In this medium the bile concentration is reduced and additional sodium azide is incorporated. Bile Esculin Azide Agar, recommended by the ISO Committee (11) is a modification of Bile Esculin Azide Agar (M493), in the type of carbon sources used.
Tryptone, Peptone and yeast extract serves as sources of carbon, nitrogen, amino acids, vitamins and essential growth nutrients. Bile and sodium azide inhibits most of the other accompanying bacteria. Esculin in the medium is hydrolyzed to esculetin and dextrose. Esculetin reacts with ferric citrate to form a dark brown or black complex, visualized as a zone of black precipitate around the colonies. If the media is dispensed in tubes in the form of slants, a positive reaction is indicated by blackening of more than half of the slant within 24-48 hours. If blackening is totally absent or if less than half of the slant is blackened within 24-48 hours, the test is negative. Viridans Streptococci sometimes exhibit a weak positive reaction. Also, Leuconostoc, Pediococcus, Lactococcus species causing human infections give a positive bile esculin test (12). To enhance the growth of Enterococci, Bile Esculin Agar can be supplemented with 50ml/l horse serum (3).
Suspected water samples are filtered using membrane filters. These membrane filters are aseptically placed on Slanetz and Bartely Medium (M612I).
Red or maroon coloured colonies observed after incubation are further confirmed by aseptically transferring the membrane filter on to Bile Esculin Azide Agar plate, preheated to 44°C. Incubation at 44 ± 0.5°C for 2 hours is done following the inoculation. All typical colonies exhibiting a brown black colouration in the surrounding medium are counted as intestinal Enterococci (11). Alternatively Bile Esculin Azide Agar can also be used for direct isolation of Enterococci (without membrane filter), by incubation at 35-37°C for 18-24 hours.
Type of specimen
Water samples
Specimen Collection and Handling:
For water samples, follow appropriate techniques for sample collection and processing as per guidelines (13).
After use, contaminated materials must be sterilized by autoclaving before discarding.
Warning and Precautions :
Read the label before opening the container. Wear protective gloves/protective clothing/eye protection/ face protection. Follow good microbiological lab practices while handling specimens and culture. Standard precautions as per established guidelines should be followed while handling specimens. Safety guidelines may be referred in individual safety data sheets.
Limitations :
- Due to nutritional variations certain strains may show poor growth.
Performance and Evaluation
Performance of the medium is expected when used as per the direction on the label within the expiry period when stored at recommended temperature.
Quality Control
Appearance
Light yellow to brownish yellow coloured granular medium
Gelling
Firm, comparable with 1.5% Agar gel
Colour and Clarity of prepared medium
Amber coloured, clear to slightly opalescent solution with a bluish tinge forms in Petri plates.
Reaction
Reaction of 5.67% w/v aqueous solution at 25°C. pH: 7.2±0.2
pH
7.00-7.40
Cultural Response
Cultural characteristics observed after an incubation at 35-37°C for 18-24 hours.
| Organism | Inoculum (CFU) | Growth | Recovery | Esculin Hydrolysis |
|---|---|---|---|---|
| Enterococcus faecalis ATCC 29212 (00087*) | 50-100 | luxuriant | >=50% | positive reaction, blackening of medium around the colony |
| Escherichia coli ATCC 25922 (00013*) | >=104 | inhibited | 0% | |
| Staphylococcus aureus subsp. aureus ATCC 25923 (00034*) | 50-100 | good | 40-50% | negative reaction |
| Proteus mirabilis ATCC 25933 | 50-100 | good | 40-50% | negative reaction |
| Streptococcus pyogenes ATCC 19615 | 50-100 | none-poor | <=10% | negative reaction |
Key: *Corresponding WDCM numbers.
Storage and Shelf Life
Store between 10-30°C in a tightly closed container and the prepared medium at 20-30°C. Use before expiry date on the label. On opening, product should be properly stored dry, after tightly capping the bottle in order to prevent lump formation due to the hygroscopic nature of the product. Improper storage of the product may lead to lump formation. Store in dry ventilated area protected from extremes of temperature and sources of ignition. Seal the container tightly after use. Product performance is best if used within stated expiry period.
Disposal
User must ensure safe disposal by autoclaving and/or incineration of used or unusable preparations of this product. Follow established laboratory procedures in disposing of infectious materials and material that comes into contact with sample must be decontaminated and disposed of in accordance with current laboratory techniques (14,15).
| Product Name | Bile Esculin Azide Agar, Granulated |
|---|---|
| SKU | GM493I |
| Product Type | Granulated |
| Physical Form | Granular |
| Origin | Animal |
| Packaging type | HDPE |
| References | 1. Koneman E. W., Allen S. D., Janda W. M., Schreckenberger P. C., Winn W. C. Jr., 1992, Colour Atlas and Textbook ofDiagnostic Microbiology, 4 th Ed., J. B. Lippinccott Company 2.Meyer and Schonfeld, 1926, Zentralbl. Bakeriol, Parasitenk. Infectionskr. Hyg. Abt. Orig. 99:402. 3.MacFaddin J. F., 1985, Media for Isolation-Cultivation-Identification-Maintenance of Medical Bacteria, Vol. I, Williamsand Wilkins, Baltimore. 4.Rochaix, 1924, Comt. Rend. Soc. Biol., 90:771. 5.Facklam R., 1973, Appl. Microbiol., 26:138. 6.Swan, 1954, J. Clin. Pathol., 7:160. 7.Facklam R., 1972, Appl. Microbiol., 23:1131. 8.Facklam R. R and Moody M. D., 1970, Appl. Microbiol., 20(2):245. 9.Edberg S. C., Pittman S., and Singer J. M., 1977, J. Clin. Microbiol., 6:1 10.Isenberg, 1970, Clin. Lab. Forum, July. 11. Murray P. R., Baron E. J., Jorgensen J. H., Pfaller M. A., Yolken R. H.,(Eds.), 8th Ed., 2003, Manual of ClinicalMicrobiology, ASM, Washington, D.C.1 2.Isenberg, H.D. Clinical Microbiology Procedures Handb0ook. 2nd Edition. 13.Jorgensen,J.H., Pfaller , M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015)Manual of Clinical Microbiology, 11th Edition. Vol. 1. 14.American Public Health Association, Standard Methods for the Examination of Dairy Products, 1978, 14th Ed., WashingtonD.C. 15.Salfinger Y., and Tortorello M.L. Fifth (Ed.), 2015, Compendium of Methods for the Microbiological Examination ofFoods, 5th Ed., American Public Health Association, Washington, D.C. 16.Wehr H. M. and Frank J. H., 2004, Standard Methods for the Microbiological Examination of Dairy Products, 17th Ed.,APHA Inc., Washington, D.C.1 |
| Customized Product Available | No |
















